Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23842639)

1.

The Women's Health Initiative: Hormone Therapy and Calcium/Vitamin D supplementation trials.

Cauley JA.

Curr Osteoporos Rep. 2013 Sep;11(3):171-8. doi: 10.1007/s11914-013-0150-7. Review.

PMID:
23842639
3.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

4.
5.

Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.

Robbins JA, Aragaki A, Crandall CJ, Manson JE, Carbone L, Jackson R, Lewis CE, Johnson KC, Sarto G, Stefanick ML, Wactawski-Wende J.

Menopause. 2014 Feb;21(2):116-23. doi: 10.1097/GME.0b013e3182963901.

6.

Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.

Jackson RD, Wright NC, Beck TJ, Sherrill D, Cauley JA, Lewis CE, LaCroix AZ, LeBoff MS, Going S, Bassford T, Chen Z.

Calcif Tissue Int. 2011 Mar;88(3):198-208. doi: 10.1007/s00223-010-9449-x. Epub 2011 Jan 21.

7.
8.

Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.

Bolland MJ, Grey A, Gamble GD, Reid IR.

Am J Clin Nutr. 2011 Oct;94(4):1144-9. doi: 10.3945/ajcn.111.015032. Epub 2011 Aug 31.

9.

Calcium plus vitamin D supplementation and the risk of fractures.

Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators.

N Engl J Med. 2006 Feb 16;354(7):669-83. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.

10.

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.

Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE.

Osteoporos Int. 2013 Feb;24(2):567-80. doi: 10.1007/s00198-012-2224-2. Epub 2012 Dec 4.

11.
12.

Calcium supplementation and fracture risk--recent findings from the women's health initiative study.

Kruse H.

S D Med. 2006 May;59(5):207-8. Review. No abstract available.

PMID:
16729654
13.

Osteoporosis: new hope for the future.

Masi L, Bilezikian JP.

Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54. Review.

PMID:
9309458
14.

Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.

Di Daniele N, Carbonelli MG, Candeloro N, Iacopino L, De Lorenzo A, Andreoli A.

Pharmacol Res. 2004 Dec;50(6):637-41.

PMID:
15501704
15.

Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.

Jackson RD, Mysiw WJ.

Semin Reprod Med. 2014 Nov;32(6):454-62. doi: 10.1055/s-0034-1384629. Epub 2014 Oct 16. Review.

PMID:
25321423
16.
17.

Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.

LaCroix AZ, Kotchen J, Anderson G, Brzyski R, Cauley JA, Cummings SR, Gass M, Johnson KC, Ko M, Larson J, Manson JE, Stefanick ML, Wactawski-Wende J.

J Gerontol A Biol Sci Med Sci. 2009 May;64(5):559-67. doi: 10.1093/gerona/glp006. Epub 2009 Feb 16.

18.

A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.

Gutteridge DH, Stewart GO, Prince RL, Price RI, Retallack RW, Dhaliwal SS, Stuckey BG, Drury P, Jones CE, Faulkner DL, Kent GN, Bhagat CI, Nicholson GC, Jamrozik K.

Osteoporos Int. 2002;13(2):158-70.

PMID:
11908491
19.

Estrogen plus progestin therapy: the cardiovascular risks exceed the benefits.

Penckofer SM, Hackbarth D, Schwertz DW.

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):347-55. Review.

PMID:
14680337
20.

Osteoporosis: trials and tribulations.

Seeman E.

Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.

PMID:
9302899
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk